MedPath

The effect of hyoscine and EMLA cream on Catheter related bladder discomfort (CRBD)

Phase 3
Recruiting
Conditions
Catheter related bladder discomfort.
Other specified disorders of bladder
N32.8
Registration Number
IRCT20210228050530N1
Lead Sponsor
Gonabad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
105
Inclusion Criteria

Having ASA class 1 or 2 according to the anesthesiologist record
Age between 18 and 60 years
Elective surgery with general anesthesia and requires urinary catheterization
No history of bladder obstruction, overactive bladder, severe kidney and liver diseases, chronic pain, cerebrovascular disorders, cardiovascular diseases, psychosis, neurological bladder
Non-urological surgeries.
No history of allergy to lidocaine or prilocaine and hyoscine
No cardiac dysrhythmia
No obvious cognitive impairment
Do not take sedatives for a long time
No kidney or liver failure
No history of drug use
No untreated glaucoma, active bleeding, Paralytic ileus, chronic lung disease and secondary tachycardia due to heart failure
Medications used before and during anesthesia should be the same

Exclusion Criteria

Unwillingness to cooperate
Patients should also undergo urological surgery during the operation.
Any effective intervention or medication in addition to medications used in the routine anesthesia process

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of Catheter related bladder discomfort. Timepoint: In one, two, three and four hours after the end of anesthesia. Method of measurement: Checklist for the incidence of Catheter related bladder discomfort.
Secondary Outcome Measures
NameTimeMethod
Severity of CRBD. Timepoint: In one, two, three and four hours after the end of anesthesia. Method of measurement: Checklist of severity of CRBD of Catheter related bladder discomfort.
© Copyright 2025. All Rights Reserved by MedPath